Cytek’s commitment to expanding access to advanced cytometry is a vital contribution to global public health. By supporting under-resourced labs, they’re helping ensure that essential research can ...
FCS Express expands the flow cytometry solutions within the Insightful Science platform, enabling world-class data-driven scientific research in academia and biopharma and clinical analysis in ...
One huge reason why the world of medicine hasn't yet found "the cure" for hard-to-treat malignancies like acute myeloid ...
Australian Patent Office accepts bioAffinity Technologies' patent application for its platform technology to assess lung health and predict disease.
Affinity Technologies, Inc. ( ($BIAF) ) has issued an update. On October 16, 2025, bioAffinity Technologies, Inc. announced it received a ...
Cytek’s new facility in Amsterdam, The Netherlands, expands the company’s capacity to meet the growing demand for comprehensive cell analysis solutions. The new site houses Cytek European offices and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results